KemPharm, Inc. KMPH announced that it has strengthened its attention deficit hyperactivity disorder (ADHD) prodrug pipeline. The company announced that it will develop a new prodrug product candidate ...

Travis Mickle, CEO of KemPharm, talks about his company’s use of prodrugs, the business opportunities prodrugs represent, and how prodrugs are helping to improve patient centricity. The ...

Solid tumors are notoriously difficult to treat and often put children into a high-risk category as tumors like neuroblastoma, Ewing sarcoma, and rhabdomyosarcoma in these patients often don’t respond ...

Title: A novel and versatile Prodrug T cell engager platform with a novel candidate demonstrating potent and tumor-restricted activity Presentation Time: 9:00AM - 12:00PM, local time (Location: Poster ...

Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy for cancers that form solid tumors, including ...

Prodrug technology has been successfully utilized to develop therapeutics and treat patients for more than 100 years. Many of the world’s best known and most widely used pharmaceuticals are, in fact, ...

The current interest in prodrugs is evident. Since 2008, the FDA has approved over 30 prodrugs, and approximately 10% of all marketed drugs worldwide can be considered prodrugs. Consequently, the ...

Please provide your email address to receive an email when new articles are posted on . Using a machine learning approach, researchers found that patients on selective serotonin reuptake inhibitors ...

Researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target ...

Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type of targeted approach a “prodrug” ...